Биостатистика, фармакокинетика и клинические исследования.

Домашняя страница
- О сайте
Материалы
- Быстрые команды R Project
- Ссылки
Инструменты
- Рандомизационный список
Блог
Контакты
Профиль
- Войти
- Зарегистрироваться

Long WS Wide: или про то, как выполнить анализ разницы изменений между группами
Частые вопросы: Регистрация и экспертиза по правилам ЕАЭС
Главные ошибки при формировании базы данных в MS Excel
Тест ClinicalTrialUtilities и ReplicateBE на Raspberry Pi 4
Julia:ReplicateBE – release 0.2.0

Галерея

FDA Roundup: May 26, 2023
Source: FDA - What's New: Drugs RSS Feed Published on 2023-05-26 By FDA
Immune Globulin Hypersensitivity Reactions: Root Causes and Mitigation; Public Workshop - 03/30/2023
Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2023-05-26 By FDA
Application Submissions Guidances
Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2023-05-26 By FDA
Rare Disease Endpoint Advancement Pilot Program Frequently Asked Questions
Source: FDA - What's New: Drugs RSS Feed Published on 2023-05-26 By FDA
FDA Updating Warnings to Improve Safe Use of Prescription Stimulants Used to Treat ADHD and Other Conditions.
Source: FDA - What's New: Drugs RSS Feed Published on 2023-05-26 By FDA
An Update on Field Alert Reports (FAR) and Biological Product Deviation Reports (BPDR) - 05/24/2023
Source: FDA - What's New: Drugs RSS Feed Published on 2023-05-26 By FDA
CDER Small Business & Industry Assistance (SBIA)
Source: FDA - What's New: Drugs RSS Feed Published on 2023-05-26 By FDA
Human medicines European public assessment report (EPAR): Procysbi, mercaptamine, Cystinosis, Date of authorisation: 05/09/2013, Revision: 16, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2023-05-26
We Are Hiring
Source: FDA - What's New: Drugs RSS Feed Published on 2023-05-26 By FDA
Abbreviated New Drug Application (ANDA)
Source: FDA - What's New: Drugs RSS Feed Published on 2023-05-26 By FDA
FDA updates on hand sanitizers consumers should not use
Source: FDA - What's New: Drugs RSS Feed Published on 2023-05-26 By FDA
CDER Scientific Review Documents Supporting Emergency Use Authorizations for Drug and Biological Therapeutic Products | COVID-19
Source: FDA - What's New: Drugs RSS Feed Published on 2023-05-26 By FDA
Summary of opinion: Opdivo,nivolumab, 25/05/2023, Positive
Source: EMA - New medicines: human Published on 2023-05-26
Summary of opinion: Pylclari,piflufolastat (18F), 25/05/2023, Positive
Source: EMA - New medicines: human Published on 2023-05-26
Summary of opinion: Ztalmy,ganaxolone, 26/05/2023, Positive
Source: EMA - New medicines: human Published on 2023-05-26

Предыдущие записи

Тема: Scaffold от Danny Cooper.